Versican (Vcan) (C-Term) Antikörper

Details zu Produkt Nr. ABIN2385269
Target
Bindungsspezifität
C-Term
24
15
3
2
2
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
76
65
52
4
2
1
1
Wirt
Kaninchen
47
33
1
1
Klonalität
Polyklonal
Konjugat
Unkonjugiert
5
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Applikation
Immunohistochemistry (IHC), Western Blotting (WB)
51
29
27
15
15
13
11
4
3
3
1
1
Optionen
Immunogen A synthetic peptide corresponding to a sequence at the C-terminal of human versican, identical to the related rat and mouse sequences.
Isotyp IgG
Kreuzreaktivität Human, Maus, Ratte (Rattus)
Kreuzreaktivität (Details) Calculated cross reactivity: Hu Mo Rt
Produktmerkmale Versican/VCAN (Chondroitin sulfate proteoglycan core protein 2)
Reinigung Purified by immunoaffinity chromatography.
Target
Andere Bezeichnung Versican/VCAN (Vcan Antibody Abstract)
UniProt P13611
Pathways Glycosaminoglycan Metabolic Process
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
Buffer Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
Konservierungs-mittel Sodium azide, Thimerosal (Merthiolate)
Vorsichtsmaßnahmen This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
Lagerung 4 °C,-20 °C
Informationen zur Lagerung 4°C/-20°C